GILOTRIF for Lung neoplasm malignant: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 34 adverse event reports in the FDA FAERS database where GILOTRIF was used for Lung neoplasm malignant.
Most Reported Side Effects for GILOTRIF
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Diarrhoea | 43 | 36.8% | 8 | 15 |
| Death | 29 | 24.8% | 29 | 4 |
| Off label use | 22 | 18.8% | 5 | 4 |
| Rash | 20 | 17.1% | 4 | 5 |
| Decreased appetite | 11 | 9.4% | 3 | 2 |
| Fatigue | 11 | 9.4% | 4 | 2 |
| Nausea | 11 | 9.4% | 3 | 5 |
| Dry skin | 9 | 7.7% | 1 | 2 |
| Vomiting | 9 | 7.7% | 1 | 5 |
| Asthenia | 8 | 6.8% | 2 | 3 |
| Epistaxis | 8 | 6.8% | 1 | 3 |
| Stomatitis | 7 | 6.0% | 0 | 0 |
| Dehydration | 6 | 5.1% | 1 | 4 |
| Drug ineffective | 6 | 5.1% | 0 | 2 |
| Acne | 5 | 4.3% | 1 | 0 |
Other Indications for GILOTRIF
Non-small cell lung cancer (58)
Lung carcinoma cell type unspecified stage 0 (10)
Non-small cell lung cancer metastatic (8)
Other Drugs Used for Lung neoplasm malignant
ERLOTINIB (9,207)
OSIMERTINIB (4,754)
NIVOLUMAB (4,197)
PEMBROLIZUMAB (3,575)
CARBOPLATIN (3,487)
ALECTINIB (2,932)
PEMETREXED (2,422)
CRIZOTINIB (1,949)
BEVACIZUMAB (1,810)
PACLITAXEL (1,747)